Quiet. Please

•

Kanaal • 416 programma’s

Kunst

Kunst

Bijgewerkt 40 min. geleden
Geneeskunde

Geneeskunde

Maandelijks bijgewerkt
Natuurwetenschappen

Natuurwetenschappen

Bijgewerkt 11-06-2024
Boeken

Boeken

Maandelijks bijgewerkt
Ontwerp

Ontwerp

Maandelijks bijgewerkt
Boeken

Boeken

Bijgewerkt 22-09-2023
Opvoeding

Opvoeding

Bijgewerkt 29-08-2023

28 JAN

GLP-1 Medications Transform Weight Loss Treatment as Medicaid Coverage Remains Inconsistent Across States

The landscape of weight loss treatment in America is shifting dramatically as glucagon-like peptide-one receptor agonists, or GLP-1s, continue to dominate conversations about obesity management. According to a Pew Research Center report from January 2026, thirteen states now cover GLP-1s for obesity treatment under Medicaid, though this represents progress tempered by significant setbacks. California, New Hampshire, Pennsylvania, and South Carolina stopped covering these medications as of January first, citing rising costs that have strained state budgets. The medications, which include popular drugs like Ozempic and Wegovy, have seen explosive growth, with Novo Nordisk reporting thirty-one point one billion dollars in combined revenue from these three drugs in 2024, nearly triple the eleven point nine billion from 2022. Public awareness of these medications continues to surge. According to Pew Research data from early 2025, about fifty-three percent of Americans say they hear or read about Ozempic, Wegovy, and similar drugs extremely or very often. Yet Americans remain divided on appropriate use. While fifty-three percent of those familiar with these medications see them as good options for people with obesity or weight-related health conditions, only twelve percent view them as appropriate for people who simply want to lose weight without existing health issues. Oprah Winfrey has been particularly vocal about her GLP-1 journey, recently speaking with CBS about her experience with these medications. In an interview from January 12, 2026, the seventy-one-year-old media mogul described how the medication eliminated what she calls "food noise" within hours of her first dose. She expressed deep regret that she did not discover this treatment option in 2013, speaking emotionally about the wasted years of shame and sadness surrounding her weight struggles. Winfrey now views obesity as a disease rather than a personal failure, a perspective shift that has transformed her relationship with these medications. After taking herself off the drug for a year to prove she could manage without it, she gained twenty pounds and has since recommitted to the treatment, recognizing that like her blood pressure medication, these drugs represent a long-term management tool she needs to maintain her health. The first week of 2026 has highlighted the complex reality of weight loss medication access in America. While newer treatments continue to emerge and awareness spreads, insurance coverage remains inconsistent and often declining. The tension between rising demand, limited access through public programs, and growing pharmaceutical revenues underscores the ongoing challenges in making these transformative treatments available to all Americans who need them. Thanks for listening. Please subscribe and remember, this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot AI. We'll be back next week with more. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI

28 jan

•

3 min
29-09-2023

Creepy Sounds

Step into the eerie world of a Spooky Sounds Podcast, where every creaking door, howl, and thunderclap transports you to a realm of spine-tingling atmospheres. This auditory experience offers a diverse collection of unsettling and mysterious sounds, including the haunting echoes of screams, chains rattling, and the ominous whistling of the wind. With the distant calls of owls, the unsettling caws of crows, and the chilling barks of wolves, these podcasts are a treasure trove of all things eerie and atmospheric.Spooky sounds podcasts serve a multitude of purposes, making them an indispensable addition to any playlist:Creating Haunting Ambiance: Perfect for setting the stage at Halloween parties or within the dimly lit corridors of a haunted house, these podcasts can instantly elevate the spooky atmosphere.Enhancing Horror Entertainment: Whether you're watching a bone-chilling horror movie or immersing yourself in a gripping video game, these soundscapes add an extra layer of suspense and fear.Relaxing Amidst Spooky Vibes: Sometimes, you don't need a special occasion to indulge in the thrill of the supernatural. Simply tune in, close your eyes, and let the eerie sounds wash over you as you unwind.Fueling Halloween Preparations: As you deck out your home with ghoulish decorations or embark on the age-old tradition of pumpkin carving, let the spooky sounds podcast serve as your chilling backdrop.Enchanting Nighttime Adventures: Take your headphones, venture into the dark woods, and let your imagination run wild as these sounds weave tales of the unknown around you.Perfect for Themed Parties: Elevate your Halloween gathering or haunted house experience with these carefully curated soundscapes, creating an immersive and spine-tingling environment.Simple Enjoyment: Sometimes, all you need is to sit back, relax, and savor the eerie vibes that these podcasts bring, letting your mind wander through haunted landscapes and spectral echoes.Whether you're using them for festive occasions, entertainment, or simply to infuse a little thrill into your daily routine, spooky sounds podcasts are your gateway to a world of captivating and hair-raising auditory experiences. So, prepare to be entranced, captivated, and thoroughly spooked as you embrace the spectral delights of these podcasts, ensuring that every moment becomes a journey into the unknown. This content was created in partnership and with the help of Artificial Intelligence AI

29-09-2023

•

16 min
6 DGN GELEDEN

Oprah at 72: Gym Gains, New App Launch, and Her Honest Health Journey

Oprah Winfrey BioSnap a weekly updated Biography. Oprah Winfrey dined at an iconic off-Strip Las Vegas restaurant on February 5 according to the Las Vegas Review-Journal a rare public sighting that sparked buzz among locals and fans eyeing her every move. Just days earlier on February 2 WHNT News 19 captured her deadlifting impressive weights in a gym session to mark turning 72 channeling strength training recommended by friend Adele after getting new knees two summers back. She shared that workout grind on Instagram around January 29 as OK Magazine reported turning her birthday into a rigorous 72-minute cardio blitz on treadmill bike climber and ski machine gasping I dont know my name at the end while vowing to ditch self-shaming on her health journey. On Oprah Daily February 1 she penned a poignant reflection cherishing 72 as a privilege of distillation where noise fades truth amplifies and aging means savoring walks laughs and clarity not decline. AOL noted her recent Today Show confession from January 13 gaining 20 pounds after quitting GLP-1 meds to test her hiking resolve only for food noise to roar back underscoring her raw ongoing weight saga with potential to shape her biographical legacy on resilience. Business stays sharp with MediaPost highlighting her beta launch of The Oprah Insider Community app tied to Oprah Daily letting fans chat debate books and share aha moments with Gayle King and crew a digital haven for empathy she touted as a fan boon. Oprah Book Club via Parade on January 19 hyped 2026 reads topping with Pulitzer winner Jayne Anne Phillips Small Town Girls out April 21 amid her own wellness book Enough dropping this month. Ignore viral pink salt recipes CTC fact-checks confirm she never endorsed those gimmicks. No fresh social flares beyond her intention video but her empire hums proving at 72 shes lifting more than barbells.[347 words] Get the best deals https://amzn.to/3ODvOta This content was created in partnership and with the help of Artificial Intelligence AI

6 dgn geleden

•

3 min
3 JAN

Oprah's Weight Loss Revelation: Quitting Alcohol, GLP-1, and Her New Book Enough

Oprah Winfrey BioSnap a weekly updated Biography. I'm Perplexity, not Biosnap AI, so I'll provide you with verified information about Oprah Winfrey's recent activities based on the search results available. Oprah Winfrey has been making significant headlines as she enters 2026 with major personal and professional announcements. The media maverick graced the cover of People Magazine discussing her weight loss journey in detail, revealing candid insights about her relationship with alcohol and prescription medications. According to Black Enterprise, Winfrey disclosed that consuming seventeen shots of tequila in a single night prompted her to quit alcohol entirely, stating that she no longer even desires it. She's been open about her two-year journey with GLP-1 weight loss medication, acknowledging that after stopping the drug in 2024, she regained the weight and now recognizes she'll need to remain on it long-term for sustained results. Her new book titled "Enough: Your Health, Your Weight, and What It's Like To Be Free" launched on January third and marks a significant milestone in her public discussion of obesity, a term she previously avoided. The book represents a collaboration with Dr. Ania M. Jastreboff, founding director of the Yale Obesity Research Center, combining personal narrative with scientific research. Professionally, Winfrey is scheduled for a major public appearance on January thirteenth at Kaufmann Concert Hall in New York, where she and her longtime friend Gayle King will engage in a candid conversation about food, fulfillment, and obesity research. According to event listings, tickets for this event are currently available through multiple platforms, with prices ranging from one hundred thirty-six dollars to over four hundred dollars depending on seating. The timing of these announcements reflects Winfrey's deliberate effort to normalize conversations around weight management and obesity while sharing her personal struggles and victories. Her willingness to discuss previously taboo topics—including her consumption habits and reliance on pharmaceutical interventions—demonstrates a shift toward transparency that resonates with her audience during awards season and the beginning of the new year. These developments position her not merely as a celebrity but as an advocate for health conversations grounded in scientific understanding. Get the best deals https://amzn.to/3ODvOta This content was created in partnership and with the help of Artificial Intelligence AI

3 jan

•

3 min
7 FEB

Biography Flash: Travis Scott and Kylie Jenner Face Backlash Over Kids Birthday Party Astroworld Theme

Travis Scott Biography Flash a weekly Biography. Hey loves, its your girl Roxie Rush here on Biography Flash, and yeah, Im an AI dishing the hottest scoops faster than you can say sold-out stadiumyour go-to for Travis Scott tea because I sift through the chaos without the drama, keeping it real and rapid-fire. Buckle up, because the past few days have been a whirlwind for our rage-rap king. Major headline alert from the last 24 hours: Kylie Jenner and Travis Scott are catching absolute heat over their kids Stormi and Aires double birthday bash last weekendFebruary 1 for eight-year-old Stormi, February 2 for four-year-old Aire. According to UNILAD and Bored Panda, the desert-themed extravaganza at Kylies LA pad featured epic rock sculptures, palm trees, cacti, Labubu toys, monster trucks, and custom Stormi World and Planet Aire signs. But oh honey, the entrance? A massive inflatable head straight out of Travis 2021 Astroworld Festivalthe one tied to that heartbreaking tragedy where 10 lives were lost, including little Ezra Blount, from compression asphyxia during crowd surges. Reddit exploded, with fans calling it disgusting, hollow, and in horrible tastepeople fking died, one wrote. Tyla reports the backlash slamming the exes as disconnected, even though Travis faced investigations but no charges, and all suits settled privately. Co-parenting goals or tone-deaf flop? You decide, but its got long-term bio weight, dredging up that Astroworld shadow. No fresh public appearances or business moves in the last few days, but rewind a couple weeks to that Rolling Stone February 2026 cover story drophe toured a jaw-dropping 65-million-dollar brutalist Beverly Hills mansion, geeking out on architecture, his Utopia tour highs like wild South Korea crowds, fatherhood vibes, Cactus Jack artists, and pleas to keep theaters alive amid streaming wars. No new social media mentions from Travis himself latelyhes keeping it low-key post-party pics shared via Kylie and fam like Khloe. Whew, thats the pulse-pounding update, darlingsstay obsessed. Thanks for tuning in, smash that subscribe so you never miss a Travis twist, and search Biography Flash for more juicy bios. Muah! And that is it for today. Make sure you hit the subscribe button and never miss an update on Travis Scott. Thanks for listening. This has been a Quiet Please production." Get the best deals https://amzn.to/42YoQGI This content was created in partnership and with the help of Artificial Intelligence AI

7 feb

•

3 min
3 FEB

Max Verstappen Powers Red Bull's 2026 F1 Season Launch at Barcelona Shakedown

Max Verstappen BioSnap a weekly updated Biography. Max Verstappen kicked off the 2026 Formula 1 season with a bang at the Barcelona Shakedown, where Formula1.com reports he was pleased with Red Bulls good start despite feeling unwell himself, declaring the team hit the ground running as they tested the new regs over five intense days. Day one highlights captured his smooth debut laps, setting a positive tone amid mixed weather, while Red Bull principal Laurent Mekies told Formula1.com its early days but great energy pulses through the squad with solid learnings already banked. Verstappen stayed front and center through days two to five, powering the RB through shakedown paces that could shape his title defense after narrowly trailing Lando Norris at 421 points to 423 in the 2025 standings per Speedcafe.com. No off-track drama or social buzz lit up the feeds in these past few days, keeping the spotlight laser-focused on track as whispers swirl this shakedown momentum might lock in Red Bulls edge for the long haul. Business stays quiet with no fresh deals announced, though his number one contender status fuels bio gold for seasons ahead. Get the best deals https://amzn.to/3ODvOta This content was created in partnership and with the help of Artificial Intelligence AI

3 feb

•

2 min
21 JAN

Oprah Winfrey Opens Up About GLP-1 Medications for Weight Loss and Calls Them Lifetime Commitment

Oprah Winfrey has been candid this week about her experiences with GLP-1 medications like Ozempic for weight loss. According to RadarOnline on January 16, she dropped about 50 pounds two and a half years ago after starting the drug but gained back 20 pounds when she stopped taking it after six months. She shared on The View and her podcast that she once blamed herself for her weight, feeling shame from constant food noise in her head, but now views obesity as a disease beyond personal control, much like addiction. Oprah explained that thin people simply do not think about food constantly, and the medication silenced that urge for her, even reducing her desire for alcohol like tequila. RadarOnline reports Oprah calling it a lifetime commitment, similar to blood pressure medicine, as stopping leads to regain despite diet and exercise. She told CBS News she is now down to 155 pounds from a default of 211, feeling in the best shape of her life at 71 through the drugs combined with daily hiking and resistance training. Oklahoma Magazine notes she has no shame in using GLP-1s, covers costs for friends, and stresses overeating does not cause obesity but the reverse, freeing her from self-blame. Experts echo this. Michigan State University Today featured physiologist Gina Leinninger this week, who calls GLP-1 drugs like Ozempic and Wegovy game-changers for obesity, mimicking hormones to curb hunger since the brain defends higher weights. She warns they are forever drugs, with effects reversing quickly upon stopping, and urges reserving them for those who need them amid shortages and high costs up to one thousand dollars monthly. Stony Brook Medicine on January 15 detailed how these injections or pills delay stomach emptying, leading to 15 percent average weight loss with semaglutide when paired with lifestyle changes, though side effects like nausea can be managed by eating smaller protein-rich meals slowly. A Los Angeles Times analysis on January 15 highlighted broader impacts, noting widespread use could save U.S. airlines over five hundred million dollars yearly in fuel from lighter passengers. Business Insider affirmed Oprah's influence persists, validating medical over willpower approaches. Thanks for tuning in, listeners, come back next week for more. Thanks for listening, please subscribe, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI

21 jan

•

3 min
17 JAN

Health Canada Approves First Daily GLP One Pill Rybelsus for Type 2 Diabetes and Heart Disease Prevention

Health Canada approved the first glucagon-like peptide one daily pill, Rybelsus, on Monday for adults with type two diabetes who face high risks of heart disease. This semaglutide pill, made by the same company behind injectable Ozempic and Wegovy, aims to improve blood sugar levels alongside diet and exercise while cutting chances of heart attacks, strokes, or death from cardiovascular events. Company trials with over nine thousand six hundred fifty patients showed it lowered those risks compared to a placebo. Unlike prior GLP one drugs in Canada, all injectables until now, this offers a convenient oral option, though experts note it may need higher doses since stomach acids break down some of the peptide, making injections potentially more effective for weight loss. Recent studies highlight challenges with these medications. A review in the British Medical Journal, published this week, analyzed sixty-three trials involving more than nine thousand people and found users regain weight at about zero point four kilograms per month after stopping GLP one drugs, with heart benefits vanishing too. In the United States, the food and drug administration approved an oral Wegovy pill last month, now available for around one hundred forty-nine United States dollars monthly through places like Amazon Pharmacy. Oprah Winfrey, seventy-one, shared candid thoughts on GLP one medications this week during appearances on CBS Sunday Morning and The View. She called them a vital tool for managing obesity, a disease she now views without shame or self-blame. Winfrey said the constant food noise in her mind vanished hours after her first dose, freeing her from obsession despite still enjoying food. She regrets not discovering them in two thousand thirteen, lamenting wasted years of sadness, and admitted gaining twenty pounds in a year after stopping to test her willpower, proving to her it is a lifelong need like blood pressure medicine. Promoting her new book with doctor Ania Jastreboff, she stressed obesity causes overeating, not the reverse, and urged ending blame, even covering costs for friends who cannot afford it. Analysts at Jefferies noted on January twelfth that widespread use of weight loss drugs like Ozempic could save major United States airlines up to five hundred eighty million dollars in fuel this year, as lighter passengers cut jet fuel needs by up to one point five percent. In Canada, semaglutide patents expired this month, paving the way for cheaper generics to boost access. Thanks for tuning in, listeners, please subscribe, come back next week for more, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI

17 jan

•

3 min
4 FEB

Novo Nordisk CagriSema Outperforms Ozempic in Phase III Trial for Type 2 Diabetes and Weight Loss

Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA1c levels by 1.91 percentage points and achieved 14.2 percent weight loss after 68 weeks, compared to 1.76 percentage points and 10.2 percent with Ozempic. No weight loss plateau occurred with CagriSema, and 43 percent of patients lost at least 15 percent of their body weight. Martin Holst Lange, Novo Nordisk's executive vice president and chief scientific officer, stated that combining semaglutide and cagrilintide delivers superior blood glucose control and weight reduction. Researchers are urging a more holistic approach to weight loss amid the Ozempic era, as reported by Medical Xpress on February 3. Experts like Martin Binks and Raedeh Basiri from George Mason University note that GLP-1 drugs such as Ozempic cause rapid weight loss but can lead to nutrient deficiencies, muscle loss, and struggles without proper nutrition, exercise, and psychological support. Many patients receive only prescriptions without multidisciplinary care, and access remains limited by cost and insurance gaps. Binks predicts broader availability with upcoming pill forms. A study highlighted by Science Daily on January 29 warns of rapid weight regain after stopping drugs like Ozempic, with people regaining about 0.4 kilograms per month, often faster than with diet and exercise alone. Heart health and diabetes risk improvements also reverse quickly, emphasizing the need for long-term strategies beyond medication. Oprah Winfrey has shared her experiences with GLP-1 medications, similar to Ozempic, in recent interviews covered by AOL and other outlets. At 71, she regrets not using them sooner, saying they silenced the food noise in her head and helped her view obesity as a disease, not a personal failure. She gained 20 pounds after stopping briefly but now sees these drugs as a lifelong tool, like blood pressure medication, and encourages others without shame. These developments show evolving options and cautions in weight loss treatments. Listeners, thanks for tuning in, please subscribe, and remember, this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI

4 feb

•

3 min
3 FEB

Ozempic: The Revolutionary Weight Loss Solution Transforming Health Today

Welcome to Ozempic Weightloss Unlocked, the podcast where we dive deep into the latest developments surrounding Ozempic and how it's reshaping conversations about weight management and health. I'm your host, and today we're exploring what's new in the world of this groundbreaking medication. Ozempic, originally developed as a treatment for type two diabetes, has become one of the most talked about medications in recent years. What started as a diabetes management tool has evolved into something much broader, with millions of people exploring its potential for weight loss and metabolic health. Recent clinical data continues to show impressive results. Studies indicate that individuals using Ozempic have experienced significant weight reduction, with some participants losing up to fifteen percent of their body weight over the course of a year. But beyond the numbers, we're seeing real conversations about how this medication is affecting people's lives and relationships with food. The landscape around Ozempic is changing rapidly. Healthcare providers are becoming more informed about appropriate prescribing practices, and insurance companies are adjusting their coverage policies. Demand remains exceptionally high, which has created supply chain challenges that manufacturers are actively working to address. It's important to note that Ozempic works best as part of a comprehensive approach that includes lifestyle modifications, nutrition guidance, and ongoing medical supervision. The medication itself is not a standalone solution but rather a tool that can support meaningful health changes. As we move forward, expect to hear more about long term studies, additional medical applications, and evolving guidelines for use. The conversation around Ozempic continues to mature as we learn more about its potential and limitations. Thank you for tuning in to Ozempic Weightloss Unlocked. Please subscribe to stay updated on the latest news and insights. This has been a Quiet Please production. For more, check out quietplease dot ai. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI

3 feb

•

2 min

The Quiet. Please Podcast Network – Inform, Entertain, and Inspire. Quiet. Please is a next-generation podcast network where curiosity meets creativity. Our original shows are hosted by a diverse roster of unique personalities — each with their own voice, style, and expertise — designed to inform, entertain, and inspire. From true crime and history to wellness, sports, and finance, every podcast delivers answers to the questions people are asking, while bringing fresh perspectives and unforgettable storytelling.

Provider